Gene · 85340
Papers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,295
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia. | Hum Genet | 2023 | 37878144 | PubTator, text mining | PubMed |
| 2023 APHL/ISNS Newborn Screening Symposium. | Int J Neonatal Screen | 2023 | 37873845 | PubTator, text mining | PubMed |
| Role of fetal hemoglobin in the development and progression of retinopathy of prematurity in preterm infants. | Indian J Ophthalmol | 2023 | 37870010 | PubTator, text mining | PubMed |
| The blood count as a compass to navigate in the ever-changing landscape of the carrier state of hemoglobinopathies: a single-center Italian experience. | Front Pediatr | 2023 | 37868262 | PubTator, text mining | PubMed |
| Synthesis of novel coumarin-based thiosemicarbazones and their implications in diabetic management via in-vitro and in-silico approaches. | Sci Rep | 2023 | 37865657 | PubTator, text mining | PubMed |
| Mass distribution campaign of long-lasting insecticidal nets (LLINs) during the COVID-19 pandemic in Uganda: lessons learned. | Malar J | 2023 | 37845711 | PubTator, text mining | PubMed |
| Undetectable high-performance liquid chromatography haemoglobin A1c on variant haemoglobin E phenotype: a case report. | Biochem Med (Zagreb) | 2023 | 37841770 | PubTator, text mining | PubMed |
| Impact of Sickle Cell Disease on Academic Performance: A Cross Sectional Study. | Patient Prefer Adherence | 2023 | 37841200 | PubTator, text mining | PubMed |
| Untapped Potential of Deep Eutectic Solvents for the Synthesis of Bioinspired Inorganic-Organic Materials. | Chem Mater | 2023 | 37840775 | PubTator, text mining | PubMed |
| Global analysis of suppressor mutations that rescue human genetic defects. | Genome Med | 2023 | 37821946 | PubTator, text mining | PubMed |
| Molecular understanding of unusual HbE-β+-thalassemia with Hb phenotype similar to HbE heterozygote: simple and rapid differentiation using HbE levels. | Ann Med | 2023 | 37816374 | PubTator, text mining | PubMed |
| Rare occurrence of hemoglobin Lepore variant in a Palestinian patient: a case report and brief literature review. | Ann Med Surg (Lond) | 2023 | 37811104 | PubTator, text mining | PubMed |
| The clinical value of hsa-miR-190b-5p in peripheral blood of pediatric β-thalassemia and its regulation on BCL11A expression. | PLoS One | 2023 | 37796993 | PubTator, text mining | PubMed |
Hemoglobin profile and molecular characteristics of the complex interaction of hemoglobin Doi-Saket [α9(A7) asn > lys, HBA2:c.30C > a], a novel α2α1 hybrid globin variant, with hemoglobin E [β26(B8) Glu > lys, HBB:c.79G > A] and deletional α+-thalassemia in a Thai family. | Ann Med | 2023 | 37796611 | PubTator, text mining | PubMed |
| Causal links of α-thalassemia indices and cardiometabolic traits and diabetes: MR study. | Life Sci Alliance | 2023 | 37788909 | PubTator, text mining | PubMed |
| Comparison of HbA2 Using High Performance Liquid Chromatography Versus Haemoglobin Capillary Zone Electrophoresis. | Indian J Hematol Blood Transfus | 2023 | 37786818 | PubTator, text mining | PubMed |
| Prevalence and Impact of HMOX1 Polymorphism (rs2071746: A > T) in Indian Sickle Cell Disease Patients. | J Lab Physicians | 2023 | 37780888 | PubTator, text mining | PubMed |
| Identification of Novel β-Tubulin Inhibitors Using a Combined In Silico/In Vitro Approach. | J Chem Inf Model | 2023 | 37774242 | PubTator, text mining | PubMed |
| Application of real-time PCR-based multicolor melting curve with automatic analysis system in pregestational and prenatal thalassemia diagnoses. | Ann Hum Genet | 2023 | 37771257 | PubTator, text mining | PubMed |
| Non-Viral Episomal Vector Mediates Efficient Gene Transfer of the β-Globin Gene into K562 and Human Haematopoietic Progenitor Cells. | Genes (Basel) | 2023 | 37761914 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/85340/papers?page=15